baber/WOPTO huggingface dataset:
Patent NZ-208380-A (NZ)
Title: The preparation of 6-(aminomethyl)penicillanic acid 1,1-dioxide derivatives and intermediate compounds
Inventor: BARTH W E
IPC: C07D499/00
Filed: 1984-06-05
Abstract: A process for the preparation of beta-lactamase inhibiting 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives. R- and S-1-(ethoxycarbonyloxy)ethyl 6-alpha-(aminomethyl)penicillanate 1,1-dioxide are specifically described.
Patent NZ-228125-A (NZ)
Title: (d) or (dl) 4-[1-(2,3-dimethylphenyl)ethyl]-1h-imidazole (medetomidine) for preoperative treatment of mammals
Inventor: MAZE MERVYN
IPC: A61K31/415
Filed: 1989-02-24
Abstract: 4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole, known as medetomidine, and in particular its d-enantiomer and salts thereof are useful in perioperative care, in particular in reducing the amount of anaesthetic it is necessary to administer.
Patent NZ-231649-A (NZ)
Title: Indan-substituted imidazole derivatives; pharmaceutical compositions and preparatory processes
Inventor: KARJALAINEN ARTO JOHANNES
IPC: C07D233/58
Filed: 1989-12-06
Abstract: Compounds of the formula: <CHEM>  wherein    X is -CH2 - or - @-  Rl is H, alkyl or benzyl, which can be substituted or unsubstituted  R2 is H, alkyl, OH or alkoxy  R3 is H, CH3, CH2CH3, OCH3 or Hal R4 is H, CH3, CH2CH3, OCH3 or Hal and Hal is halogen provided that when R2 is H or C1-3-alkyl then R1 cannot be H and  when R2 is OH or C1-3-alkoxy then X cannot be CO, and non-toxic acid addition salts and mixtures thereof are highly selective antagonists at postsynaptic  alpha 2-adrenoceptors, and are especially useful in the treatment of diabetes.
Patent NZ-232918-A (NZ)
Title: Transferrin-polycation conjugates; transferrin-polycation-nucleic acid complexes; pharmaceutical compositions and methods for introducing nucleic acids into cells
Inventor: BEUG HARTMUT DR
IPC: C12N15/87
Filed: 1990-03-14
Abstract: The invention relates to a system for the transport of nucleic acids into the cell, which takes place by receptor-mediated endocytosis. A complex can be formed with the polyanionic nucleic acid with the aid of a transferrin-polycation conjugate. This complex is bound to the transferrin receptor, of which there is high regulation in growing cells, and is absorbed into the cell. Suitable nucleic acids are those which inhibit specific genes or RNA function, such as antisense oligonucleotides or ribozymes, or the genes coding therefor. The invention further relates to a process for introducing nucleic acids into the cell, to transferrin-polycation/nucleic acid complexes and to pharmaceutical compositions containing these.
Patent NZ-235341-A (NZ)
Title: Bitumen free isocyanate prepolymer containing a substituted diphenylmethane
Inventor: PHANOPOULOS CHRIS
IPC: C08G18/08
Filed: 1990-09-17
Abstract: A bitumen-free liquid prepolymer composition comprising :   a) from 50 to 99% by weight of an isocyanate-containing prepolymer obtained by the reaction of a stoichiometric excess of diphenylmethane diisocyanate with an organic compound containing a plurality of isocyanate-reactive groups, and b) from 50 to 1% by weight of a substituted diphenylmethane compound which is free from ester groups, isocyanate groups and isocyanate-reactive groups and has a melting point below 25 DEG C, a boiling point above 150 DEG C and a fire point above 100 DEG C.   The composition has a good stability and is useful for preparing elastomers and foams.
Patent NZ-237734-A (NZ)
Title: Cyclopentylamines, their preparation and medicaments thereof
Inventor: FARR ROBERT ALLAN
IPC: C07H15/203
Filed: 1991-04-08
Abstract: Substituted (1 alpha , 2 beta , 3 alpha  or  beta , 4 alpha  5 alpha or  beta )-2,3,4-trihydroxy-5-(hydroxymethyl)cyclopentylamines are inhibitors of alpha-mannosidase and alpha-fucosidase and are useful immunostimulants, antiviral and antimetastatic agents.
Patent NZ-239906-A (NZ)
Title: Foil and method of producing it; strip or web of metallic foil coated with plastics material to provide scratch protection
Inventor: SCHMOOCK HELMUTH
IPC: B32B37/24
Filed: 1991-09-23
Abstract: In a foil (film, sheet) having at least two surfaces which are essentially plane-parallel to one another, at least one of the surfaces is provided with a metal layer. On its metallic surface, the metal layer is covered over the entire area by a layer which adheres strongly thereto. The protective layer is formed by an organic product which adheres strongly to the metallic surface. The organic product can be in the form of a synthetic resin having a molecular weight of greater than 10,000 kp. The synthetic resin may be in the form of a coating resin. The organic product may alternatively be in the form of a synthetic wax having a molecular weight of less than 10,000 kp. The wax does not smear (lubricate). The organic product may be in the form of a natural resin. It comprises rubber. The organic product may be in the form of a natural wax. The natural wax does not smear (lubricate). The organic product is in the form of a print primer which simplifies printing of the metallic surface. It may also be in the form of a mixture of synthetic resin and natural resin and/or in the form of a mixture of resin and wax. The protective layer can comprise a lubricating substance mixed with a synthetic resin and/or a lubricating substance mixed with a natural resin. <IMAGE>
Patent NZ-240557-A (NZ)
Title: Bulk material container stiffened to resist lateral shear
Inventor: BOOTS GERARDUS ANTHONIUS MARIA
IPC: B65D88/22
Filed: 1991-11-12
Abstract: A container for bulk materials, fluids and the like, comprising an enveloping member and an inner member which is connected to the enveloping member at at least four positions spaced along the circumference of the enveloping member, the arrangement being such that in filled condition a substantially block-shaped unit with substantially flat walls is obtained, the container further comprising a U-shaped stiffening member which comprises a web and two legs connecting thereto and is made of a material with a stiffness of its own, arranged so that the legs abut two opposite walls of the block-shaped unit and the web abuts the bottom wall of the block-shaped unit, the legs, at least in the areas adjacent their free upper edge, having a width corresponding substantially to that of the adjacent wall of the block-shaped unit and the U-shaped stiffening member being connected to the enveloping member at least in the areas referred to. <IMAGE>
Patent NZ-242173-A (NZ)
Title: Polymeric carrier stock for machine application to identical containers, typically beer cans: pull tab in stock container aperture
Inventor: MARCO LESLIE S
IPC: B65D71/50
Filed: 1992-03-31
Abstract: Carrier stock (16) formed from a single sheet of resilient polymeric material, such as low density polyethylene, for machine application to substantially identical containers (10). The stock (16) is severable to form individual carriers with three longitudinal rows of container-receiving apertures (18), as defined by band segments (30,32,34,38), which include cross segments (34,38) formed with tear-open tabs (22). The cross segments (34,38) formed with such tabs (22) are slitted (60,62,64) so as to define a series of frangible bridges (70,72,74), which are staggered transversely, and which can be easily torn by a user pulling on such tabs (22). Also, a distal portion (44) of each tab (22) is connected to another band segment by a frangible web (46), which is slitted (48). <IMAGE>
Patent NZ-247907-A (NZ)
Title: Gnrh peptide conjugate to e.coli fimbrial-filaments and vaccine containing it
Inventor: VAN DER ZEE ANNA
IPC: A61K47/48
Filed: 1993-06-16
Abstract: The present invention is concerned with vaccination of mammals against GnRH. The vaccine comprises a GnRH peptide conjugate to E. coli fimbrial-filaments and elicits an immune response against GnRH.
Patent NZ-260964-A (NZ)
Title: Heat-shrinkable, puncture-resistant biaxially stretched film comprising ethylene-alpha-olefin polymer in which the film shrinks at least 45 percent in at least one direction at 90 degrees c
Inventor: GEORGELOS PAUL NICK
IPC: B29C61/06
Filed: 1994-07-08
Abstract: A biaxially stretched film with very high heat shrink and puncture resistance properties, formed of low density ethylene alpha olefin copolymer having low melt index, low Mw/Mn, and melting point below about 102 DEG C.
Patent NZ-263721-A (NZ)
Title: Crystalline benzathine salt of cefonicid n,n'-dibenzylethylene diamine-7-[(hydroxyphenylacetyl)amino-8-oxo-3-[[[1-(sulfomethyl)-1h-tetrazol -5-yl]thio]methyl]-5-thia-1-azabicyclo-[4,2,0]oct-2-ene-2-carboxylate, preparation thereof
Inventor: POLANSKY THEODORE JOHN
IPC: A61P31/04
Filed: 1994-03-24
Abstract: A new salt form of cefonicid and its method of preparation is disclosed.
Patent NZ-296893-A (NZ)
Title: Treatment/prevention of adverse reactions to skin irritants by administration of a loop diuretic optionally in conjunction with a mast cell degranulator or a glucocorticosteroid;transdermal delivery device
Inventor: WILLE JOHN J
IPC: A61K31/19
Filed: 1995-11-16
Abstract: Methods and devices for preventing and/or treating an adverse reaction of the skin to the presence of a skin-sensitizing and/or skin-irritating agent by administering an effective amount of a loop diuretic alone or in combination with at least one mast cell degranulator or at least one glucocorticosteroid.
Patent NZ-312409-A (NZ)
Title: Process for preparing low-ash phenol-formaldehyde resole resins using a strongly basic tertiary amino alcohol as catalyst
Inventor: WU GAOMING
IPC: C08G8/10
Filed: 1996-06-24
Abstract: A process for preparing ashless and low-ash phenolic resole resins having no amine odor, and a process for preparing storage-stable mixtures or premix solutions of phenol-formaldehyde resin and urea or unrea-formaldehyde resins. These processes react phenol and formaldehyde in the presence of an effective catalytic amount of a low-volatile and strongly basic tertiary amino alcohol either alone or in combination with an inorganic base.
Patent NZ-328432-A (NZ)
Title: Tricyclic bis-imide derivatives and medicaments
Inventor: LAVIELLE GILBERT
IPC: A61K31/47
Filed: 1997-07-25
Abstract: Bis-imides of formula (I), their isomers and salts are new. m, n = 0 or 1; X, Y = H, halo, 1-6C alkyl, 1-6C trihaloalkyl, 1-6C alkoxy, OH, CN, NO2, amino, alkylamino, or dialkylamino; Z = 4-12C alkylene chain optionally interrupted by groups NR, O, S, SO, SO2, CONH, or an optionally substituted heterocycle; R = H or 1-6C alkyl; A, with two adjacent C atoms of the phenyl ring to which it is attached, forms one of the following groups, all of which may be substituted: phenyl, naphthyl, tetrahydronaphthyl, 1,4-dioxo-1,2,3,4-tetrahydronaphthyl, or a heterocycle; the ring containing B forms a group of formula (i) or (ii); m1, n1, X1, Y1, and A1 are as defined for m, n, X, Y, and A respectively; and X2 and Y2 are as defined for X and Y.
Patent NZ-330209-A (NZ)
Title: Method for fighting against myiasis affecting cattle and sheep populations using N-phenylpyrazoles derivatives
Inventor: JEANNIN PHILIPPE
IPC: A61K31/4439
Filed: 1997-08-19
Abstract: The invention concerns a method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same. The composition when used for controlling myiasis including from larvae of Calliphonidae, Oestridae, Dematobia hominis, Hypoderma bovis, Hypoderma lineatum, Cochliomya hominivorax, Cochliomya macellaria or combination thereof in cattle and sheep, which contains, in a vehicle which is suitable for administration to the animal via route which results in systemic distribution, an effective larvicidal amount, sufficient for a duration of control of at least one month, of a compound of the formula herein described. In which R1 is a halogen, CN or methyl R2 is S(O)nR3 or haloalkyl R3 is alkyl or haloalky R4 is H or halogen, or radical NR5R6, S(O)mR7, C(O)R7 or C(O)OR7, alkyl, haloalkyl or OR8 or a radical N=C(R9)(R10) R11 is a hydrogen or halogen atom and optionally CN or NO2, but H or halogen being preferred X is a trivalent nitrogen atom or a radical C-R12, the other three valencies of the carbon atom forming part of the aromatic ring
Patent NZ-510199-A (NZ)
Title: Food additive derived from an unrefined plant protein with gel properties
Inventor: ALTEMUELLER ANDREAS G
IPC: A23L11/00
Filed: 2001-02-27
Abstract: A functional food ingredient comprising an unrefined plant protein material having at least two of the following properties; a) forming a gel having a gel weight of at least 30 grams at a temperature of from 15°C to 25°C in a fluid ounce mixture of 5 parts water per 1 part plant protein material, by weight; b) forming an unrefined plant protein material/water mixture having refrigerated gel strength of at least 50 grams when mixed with 5 parts of water per part of unrefined plant protein material; c) having a nitrogen solubility index of from 30% to 80%; d) forming a aqueous slurry having a viscosity of at least 500 centipoise at a temperature of 15°C to 25°C when mixed with 7 parts of water per part of unrefined plant protein by weight; e) having a water hydration capacity of at least 3.75 times the weight of the unrefined plant material; and f) having a salt tolerance index from 30% to 80%.
Patent NZ-512446-A (NZ)
Title: Alkynyl containing hydroxamic acid compounds as TACE inhibitors
Inventor: LEVIN JEREMY IAN
IPC: A61K31/445
Filed: 2000-01-27
Abstract: The invention concerns compounds of formula (I) which are useful in treating disease conditions mediated by TNF-alpha, such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss.
Patent NZ-517276-A (NZ)
Title: Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
Inventor: SCHOENEN JEAN
IPC: A61P25/06
Filed: 2000-08-26
Abstract: The use of a racemic a-lipoic acid or its enantiomers, or pharmaceutically acceptable salts, amides, esters or thioesters, in reduced or oxidized form, in the manufacture of a medicament for the prevention or acute or chronic treatment of migraine.
Patent NZ-517765-A (NZ)
Title: Treatment of allergic rhinitis with a histacalin protein (a vasoactive amine binding protein of the same protein family as FS-HBP)
Inventor: PAESEN GUIDO CHRISTIAAN
IPC: A61K38/17
Filed: 2000-08-24
Abstract: A histacalin protein can be used in the manufacture of a medicament for the treatment or prevention of allergic rhinitis. Preferably the protein is derived from a blood feeding ectoparasite such as a tick and is the MS-HBP1, FS-HBP1, FS-HBP2 or D.RET6 protein.
Patent NZ-520027-A (NZ)
Title: A desk of pentagonal shape and desking island system
Inventor: BURAK EDWARD JOHN
IPC: A47B1/08
Filed: 2002-07-05
Abstract: A desk includes a worktop 1 of pentagonal shape with rear 11, forward and side edges 10. The forward edge includes two portions 12 of equal length and at an angle of 120 degrees to each other, and each side edge 10 is equal in length to the forward edge portions. The desks may be nested into a variety of workstation and conference groups.
Patent NZ-520776-A (NZ)
Title: Fusion protein comprising erythropoietin (EPO) and the carboxy terminal peptide (CTP) of a human chorionic gonadotropin (HCG) beta subunit
Inventor: LEE DONG-EOK
IPC: C07K19/00
Filed: 2002-08-14
Abstract: A non-naturally occurring fusion protein comprises human erythropoietin (EPO) having a carboxy terminal and a mutant linked to the carboxy terminal. The mutant is a peptide having an amino acid sequence from position 7 to position 34 in SEQ ID NO:1 with an amino acid substitution at the positions 10, 16, 21 or 27 of SEQ ID NO:1. Preferably the position is replaced with alanine. Also described is a nucleic acid encoding the protein and a vector and cell comprising the nucleic acid.
Patent NZ-525236-A (NZ)
Title: Modafinil (C5H15NOS), 2- (benzhydryl-sulfinyl) acetamide, aka 2- [(diphenylmethyl) sulfinyl] acetamide in compositions of suspended particles, methods of preparation and uses thereof
Inventor: JACOBS MARTIN J
IPC: A61P25/28
Filed: 2001-10-11
Abstract: Particle-forming compositions of modafinil compounds, and aqueous compositions of particles, wherein the particles comprise a modafinil compound, are disclosed, along with methods of their preparation, and their use in the treatment of conditions such as sleepiness, tiredness, Parkinson's Disease, cerebral ischemia, stroke, sleep apnoeas, eating disorders, attention deficit hyperactivity disorder, cognitive dysfunction or fatigue; and for the promotion of wakefulness, stimulation of appetite, or stimulation of weight gain to a patient in need thereof.
Patent NZ-531021-A (NZ)
Title: Baby carrier harness
Inventor: REFSUM BJORN
IPC: A47D13/02
Filed: 2002-07-11
Abstract: A small and neat harness (1) of light weight, which may be carried by the child as a garment, gives the child ample freedom of movement when it walks on its own, yet support while being carried. The harness may swiftly be coupled to and from a carrying strap (14) in order to carry the child, or for example to a pram or chair as a safety harness. The harness (1) may in addition be used as a walking or safety harness when the child wants to walk by itself.
Patent NZ-532218-A (NZ)
Title: Selective oxidation of a fluid stream using platinum group metals as catalysts
Inventor: COLLIER PAUL JOHN
IPC: B01J29/44
Filed: 2002-10-04
Abstract: A process for the selective oxidation of one or more components of a fluid stream is disclosed, wherein the process comprises contacting the fluid stream with an platinum group metal based oxidation catalyst at a selected temperature and providing a source of oxygen. The oxidation catalyst comprises a catalyst substrate preferably of an oxidic material that is provided with a substantially continuous coating of a molecular sieve material preferably comprising a zeolite. The process is applicable to both gas phase and liquid phase selective oxidations.
Patent NZ-534839-A (NZ)
Title: Peptide deformylase inhibitors
Inventor: AUBART KELLY M
IPC: A61P31/04
Filed: 2003-03-12
Abstract: Disclosed are compounds of formula (I), wherein: R1 is alkyl, alkyl-Ar or Ar, R2 is H, alkyl, alkyl-Ar', NR4, N(CO)R4, alkyl-NR3R4, alkylC(O)NR3R4, alkylC(O)Ar', alkyl-NHC(O)NR3R4, alkylNHC(O)Ar' or alkylSO2R4, Ar is optionally substituted phenyl, furyl, or thienyl, Ar' is optionally substituted phenyl, naphthyl, furyl, pyridyl, thienyl, thiazolyl, isothiazolyl, pyrazolyl, triazolyl, tetrazolyl, imidazolyl, imidazolidinyl, benzofuranyl, indolyl, thiazolidinyl, isoxazolyl, oxadiazolyl, thiadiazolyl, pyrrolyl, or pyrimidyl, A is N(CHO)OH, X is NH, Y is C(O). The compounds are used for the manufacture of medicaments for treating bacterial infections.
Patent NZ-535237-A (NZ)
Title: Merchandise labeling
Inventor: LUDLOW ROBERT B
IPC: G09F3/08
Filed: 2004-09-10
Abstract: A flat merchandising label is formed by flatly bonding tag 12 to a flexible elastic layer 16 which includes an integrated fastening loop 20. Bond zone 14 is not subject to the tension forces arising when fastening loop 20 is stretched, decreasing the necessary strength of the bond between flat tag 12 and elastic layer 16. When the label is affixed to merchandise tag 12 is not distorted, making it suitable for use with barcode labeling techniques.
Patent NZ-539343-A (NZ)
Title: Living body growth and therapy promotion condition collection information processing device
Inventor: YONEDA KENJI
IPC: G06Q10/00
Filed: 2003-09-26
Abstract: Irradiation light to a living body by light irradiation means is at least controlled, and an information processing device is communicably connected to a plurality of control devices for accelerating the growth or therapy of the living body. Environmental data, produced by one control device, about environments, such as the growth of the living body, including irradiation light to the living body is transmitted to the information processing device and is managed by the information processing device. The environmental data from the information processing device to the one processing device are distributed to another control device. On the other hand, in the case where the environmental data are received or distributed by the information processing device, royalty data about royalty are produced in connection with a control device identifier that identifies the one control device.
Patent NZ-541561-A (NZ)
Title: Method and apparatus for recovering ink from inkjet cartridges
Inventor: MORRISS STEPHEN
IPC: B41J2/175
Filed: 2004-02-06
Abstract: Disclosed is an apparatus and method for the recovery of ink from inkjet cartridges. The apparatus includes means (1) for breaking the ink cartridges into pieces, thereby releasing any ink and compressible material or sponge from within the otherwise substantially sealed cartridges; a washing stage (2) whereby ink is removed with solvent; and a draining stage (3) where excess solvent is drained from the cartridge pieces.
Patent NZ-542155-A (NZ)
Title: Pyridylsulfonamido pyrimidines for treating diabetic nephropathy
Inventor: MANN JESSICA
IPC: A61K31/506
Filed: 2004-03-03
Abstract: Disclosed is the use of a compound of formula (I) R1 is pyridyl or thiazolyl, any of which may optionally be substituted with C1-8alkyl or C2-8alkenyl; and a) R2 is methoxy and n is zero or one; or b) R2 is chlorine and n is zero or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for lowering proteinuria.
Patent NZ-547641-A (NZ)
Title: A new process for preparation of imipenem
Inventor: BAE HYUN SEOP
IPC: C07D477/06
Filed: 2004-12-09
Abstract: Disclosed is a compound of Formula II wherein R1 is a p-nitrobenzyl or p-methoxybenzyl group; and R2 and R3 may be identical to or different from each other and are each independently a C1-6 alkyl or aryl group.
Patent NZ-548622-A (NZ)
Title: Spray-dried starch hydrolysate agglomerate product and method for preparing a spray-dried starch hydrolysate agglomerate product
Inventor: VANHOUTTE HELENA
IPC: A23L29/206
Filed: 2004-02-19
Abstract: The disclosure relates on the one hand to a spray-dried starch hydrolysate agglomerate product having the following properties: a dextrose equivalent (DE) between 5 and 35, a moisture content of < 6% by weight, an unpacked bulk density between 0,4 and 0,6 g/cm3, a compressibility of less than 10%, a particle size distribution whereby less than 5% by weight is bigger than 500 micron and less than 5% by weight is smaller than 53 micron, an average particle size of between 150 - 250 micron, a mechanical stability of > 95%d, a static angle of repose (SAOR) of less than 45 DEG , as a measure for flowability; and a dissolution speed of < 180 seconds. On the other hand, the disclosure relates to a method for preparing a spray-dried starch hydrolysate agglomerate product in a spray-drying tower, comprising spraying a liquid material onto a solid powder material, whereby the liquid material is atomised by means of one or more two-fluid nozzles using a fluid for heating and conveying this material, and whereby the agglomerated spray-dried starch hydrolysate is produced by injecting the solid powder material in the top of the drying tower in such a way that the trajectory of the powder crosses the spray pattern of the atomised liquid material, and wherein the liquid material which is atomised by one or more two-fluid nozzles is a starch hydrolysate solution, whereby this starch hydrolysate solution is atomised using steam as said fluid.
Patent NZ-555046-A (NZ)
Title: Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
Inventor: BOGEVIG ANDERS
IPC: C07D/
Filed: 2005-12-05
Abstract: Disclosed is a pyrimidin-4-one compound of formula I wherein at least one of X and Y represents S, and the other represents O or S; and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of formula I in the manufacture of a medicament for the treatment or prophylaxis of diseases or conditions in which inhibition of the enzyme MPO is beneficial such as neuroinflammatory disorders, multiple sclerosis, atherosclerosis and COPD. Also disclosed is a process for the preparation of compounds of formula I.